Back to Search
LOUIS ARONNE, M.D.
M.D.
Internal Medicine Physician
NPI: 1316077050Individual
Specialties, Licenses & Credentials
Research & Publications (20)
The endocannabinoid system as a target for obesity treatment.
PMID 19046740·Clin Cornerstone·2008
8-other
Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: efficacy.
PMID 18154742·Am J Cardiol·2007
6-review
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.
PMID 17504894·J Clin Endocrinol Metab·2007
3-trial
Is rimonabant a safe and effective treatment for obesity?
PMID 17356520·Nat Clin Pract Endocrinol Metab·2007
8-other
Overweight and obesity: key components of cardiometabolic risk.
PMID 18452840·Clin Cornerstone·2007
6-review
Gastric pacing is not enough: additional measures for an effective obesity treatment program.
PMID 15479586·Obes Surg·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1165 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 583-1000
Quick Facts
- NPI
- 1316077050
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile